1. Signaling Pathways
  2. Vitamin D Related/Nuclear Receptor
  3. VD/VDR

VD/VDR

Vitamin D; Vitamin D receptor

Vitamin D is a secosteroidalprohormone, it can be synthesized at sufficient levels in skin, given adequate skin exposure to UV B radiation from sunlight. Vitamin D modulates its biological effects by directly regulating target gene expression through the Vitamin D receptor (VDR), a ligand-regulated transcription factor and a member of the nuclear receptor superfamily. Whether synthesized in the skin or ingested, vitamin D requires two hydroxylation steps to become the biologically active hormone, 1,25-dyhydroxyvitamin D3 [1,25(OH)2D3], a form that signals through the VDR. The hormone-bound VDR modulates target gene transcription in response to vitamin D. VDR acts as a master transcriptional regulator of autophagy. Activation of the VDR by vitamin D induces autophagy and an autophagic transcriptional signature in breast cancer (BC) cells.

There are 2 forms of vitamin D. Vitamin D2 (ergocalciferol) comes from irradiation of the yeast and plant sterol ergosterol, and vitamin D3 (cholecalciferol) is found in oily fish and cod liver oil and is made in the skin. Vitamin D represents vitamin D2 and vitamin D3.

Topical agents containing active vitamin D3 (calcitriol, 1α, 25- dihydroxyvitaminD3, VD3) analogues such as Tacalcitol, Calcipotriol and Maxacalcitol are widely used for psoriasis therapy.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-13332
    Calcifediol-d6
    Activator 98.91%
    Calcifediol-d6 is the deuterium labeled Calcifediol. Calcifediol, a major circulating metabolite of vitamin D3, is a potent VDR inhibitor[1][2].
    Calcifediol-d<sub>6</sub>
  • HY-15830
    25,26-Dihydroxyvitamin D3
    Activator
    25,26-Dihydroxyvitamin D3(25,26-dihydroxycholecalciferol) is a metabolite of vitamin D3 with intestinal calcium transport activity.
    25,26-Dihydroxyvitamin D3
  • HY-15332
    Alfacalcidol-d6
    Activator ≥98.0%
    Alfacalcidol-d6 is the deuterium labeled Alfacalcidol. Alfacalcidol is a non-selective VDR activator.
    Alfacalcidol-d<sub>6</sub>
  • HY-76585
    Paricalcitol-d6
    Activator 99.64%
    Paricalcitol-d6 is the deuterium labeled Paricalcitol. Paricalcitol is a agent used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure[1].
    Paricalcitol-d<sub>6</sub>
  • HY-32351S
    Calcifediol-d3
    99.06%
    Calcifediol-d3 is a deuterium labeled Calcifediol. Calcifediol, a major circulating metabolite of vitamin D3, is a potent VDR ligand.
    Calcifediol-d<sub>3</sub>
  • HY-32342
    Falecalcitriol
    Activator
    Falecalcitriol(Fulstan; Hornel) is an analog of calcitriol; has a higher potency both in vivo and in vitro systems, and longer duration of action in vivo.
    Falecalcitriol
  • HY-13294
    Impurity C of Alfacalcidol
    Activator 99.81%
    Impurity of Alfacalcidol. Alfacalcidol (1-hydroxycholecalciferol; Alpha D3; 1.alpha.-Hydroxyvitamin D3) is a non-selective VDR activator medication.
    Impurity C of Alfacalcidol
  • HY-10002A
    (1S)-Calcitriol
    98.31%
    (1S)-Calcitriol (1α,25-Dihydroxy-3-epi-vitamin-D3) is a natural metabolite of 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3). (1S)-Calcitriol exhibits potent vitamin D receptor (VDR)-mediated actions such as inhibition of keratinocyte growth or suppression of parathyroid hormone secretion.
    (1S)-Calcitriol
  • HY-15329
    Maxacalcitol-d6
    Activator 99.63%
    Maxacalcitol-d66 is the deuterated form of Maxacalcitol (22-Oxacalcitriol), which is a non-calcemic vitamin D3 analog and VDR ligand of VDR-like receptors.
    Maxacalcitol-d<sub>6</sub>
  • HY-32346
    Atocalcitol
    98.02%
    Atocalcitol, a vitamin D3 analogue, is used in the study for psoriasis.
    Atocalcitol
  • HY-13293
    Impurity C of Calcitriol
    Activator 99.84%
    Impurity C of Calcitriol, Calcitriol(1,25-Dihydroxyvitamin D3; Rocaltrol ) is the hormonally active form of vitamin D, Calcitriol is the active metabolite of vitamin D3 that activates the vitamin D receptor (VDR).
    Impurity C of Calcitriol
  • HY-13292
    Impurity B of Calcitriol
    Activator 98.04%
    Impurity B of Calcitriol, Calcitriol(1,25-Dihydroxyvitamin D3; Rocaltrol ) is the hormonally active form of vitamin D, Calcitriol is the active metabolite of vitamin D3 that activates the vitamin D receptor (VDR).
    Impurity B of Calcitriol
  • HY-13249
    1alpha-Hydroxy VD4
    Activator 98.41%
    1alpha-Hydroxy VD4 , a 1alpha(OH)D derivative, can effectively induce the differentiation of monoblastic leukaemia U937, P39/TSU and P31/FUJ cells.
    1alpha-Hydroxy VD4
  • HY-76542S
    Vitamin D2-d6
    Activator
    Vitamin D2-d6 is the deuterium labeled Vitamin D2. Vitamin D2 (Ergocalciferol), drived from plant sources or dietary supplements, could be used as supplement of Vitamin D[1][2].
    Vitamin D2-d<sub>6</sub>
  • HY-15285
    Doxercalciferol-d3
    Activator
    Doxercalciferol-d33 is the deuterated form of Doxercalciferol, which is a Vitamin D2 analog that acts as a vitamin D receptor activator (VDRA).
    Doxercalciferol-d<sub>3</sub>
  • HY-130705
    Previtamin D3
    98.68%
    Previtamin D3 is an intermediate in the production of cholecalciferol (vitamin D3).
    Previtamin D3
  • HY-32340
    Lexacalcitol
    Activator 99.42%
    Lexacalcitol (KH1060), a vitamin D analog, is a potent regulator of cell growth and immune responses. Lexacalcitol can be used for the research of graft rejection, psoriasis, cancer and auto-immune diseases.
    Lexacalcitol
  • HY-76937
    Impurity of Doxercalciferol
    Activator
    Impurity of Doxercalciferol is an impurity of doxercalciferol, which is a synthetic analog of ergocalciferol (vitamin D2), used as a agent for secondary hyperparathyroidism and metabolic bone disease, and it suppresses parathyroid synthesis and secretion.
    Impurity of Doxercalciferol
  • HY-15156
    1alpha, 24, 25-Trihydroxy VD2
    Activator 98.21%
    1alpha, 24, 25-Trihydroxy VD2 is a vitamin D analog.
    1alpha, 24, 25-Trihydroxy VD2
  • HY-131961
    Triciferol
    Agonist 98.61%
    Triciferol functions as a multiple ligand with combined VDR agonist and HDAC antagonist activities. Triciferol binds directly to the VDR (IC50=87 nM), and functions as an agonist with 1,25D-like potency on several 1,25D target genes. Triciferol induces marked tubulin hyperacetylation, and augments histone acetylation. Antiproliferative and cytotoxic activities.
    Triciferol
Cat. No. Product Name / Synonyms Application Reactivity